Cargando…
Arterial thrombotic complications in COVID-19 patients
The coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been described to predispose to thrombotic disease in both the venous and arterial circulations. We report four cases of an acute arterial occlusion in...
Autores principales: | Levolger, Stef, Bokkers, Reinoud P.H., Wille, Jan, Kropman, Rogier H.J., de Vries, Jean-Paul P.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366094/ https://www.ncbi.nlm.nih.gov/pubmed/32835150 http://dx.doi.org/10.1016/j.jvscit.2020.06.012 |
Ejemplares similares
-
The Impact of Lower Extremity Skeletal Muscle Atrophy and Myosteatosis on Revascularization Outcomes in Patients with Peripheral Arterial Disease
por: Ma, Kirsten F., et al.
Publicado: (2021) -
Preventing stroke in symptomatic carotid artery disease during the COVID-19 pandemic
por: Hellegering, Joyce, et al.
Publicado: (2020) -
Skeletal muscle atrophy and myosteatosis are not related to long-term aneurysmal subarachnoid hemorrhage outcome
por: Shen, Yuanyuan, et al.
Publicado: (2022) -
Short-Term Clinical Outcomes of Single Versus Dual Antiplatelet Therapy after Infrainguinal Endovascular Treatment for Peripheral Arterial Disease
por: Ipema, Jetty, et al.
Publicado: (2020) -
Arterial thrombotic complications in hospitalized patients with COVID-19
por: Rey, Juan R., et al.
Publicado: (2020)